This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Why Is Universal Health Services (UHS) Up 12% Since Last Earnings Report?
by Zacks Equity Research
Universal Health Services (UHS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why This 1 Medical Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.
Here's How Much You'd Have If You Invested $1000 in HCA Healthcare a Decade Ago
by Zacks Equity Research
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
HCA (HCA) Upgraded to Buy: Here's Why
by Zacks Equity Research
HCA (HCA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Here's Why HCA Healthcare (HCA) is a Strong Growth Stock
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Are Medical Stocks Lagging Aveanna Healthcare (AVAH) This Year?
by Zacks Equity Research
Here is how Aveanna Healthcare (AVAH) and HCA Healthcare (HCA) have performed compared to their sector so far this year.
HCA Healthcare (HCA) Boasts Earnings & Price Momentum: Should You Buy?
by Zacks Equity Research
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.
Here's Why HCA Healthcare (HCA) is a Strong Value Stock
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Encompass Health to Expand Florida Presence With New 50-bed Facility
by Zacks Equity Research
EHC already boasts a massive footprint of 167 hospitals in 38 states and Puerto Rico.
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Will Rising Expenses Hurt Acadia Healthcare's Q1 Earnings?
by Zacks Equity Research
ACHC's first-quarter results are likely to reflect benefits from growing revenue per patient day.
Upbeat April Jobs Data Put Focus on 3 Sector ETFs & Stocks
by Sanghamitra Saha
The U.S. economy added 177,000 jobs in April 2025, a slowdown from the downwardly revised 185,000 in March, but significantly surpassing market expectations of 130,000.
ENSG Gains 3% on Q1 Earnings Beat, Higher Patient Days Aid
by Zacks Equity Research
Ensign Group's first-quarter results gain on improved skilled services revenues and higher rental revenues. Management projects 2025 adjusted EPS to be within $6.22-$6.38.
If You Invested $1000 in HCA Healthcare a Decade Ago, This is How Much It'd Be Worth Now
by Zacks Equity Research
Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.
Why HCA Healthcare (HCA) is a Top Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.
Top Research Reports for Meta Platforms, JPMorgan Chase & Intercontinental Exchange
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Meta Platforms, Inc. (META), JPMorgan Chase & Co. (JPM) and Intercontinental Exchange, Inc. (ICE).
Can Lower Expenses Save Pediatrix Medical's Q1 Earnings?
by Zacks Equity Research
MD's first-quarter results are likely to reflect declining hospital contract administrative fees.
Humana's Q1 Earnings Beat Estimates on CenterWell Segment Strength
by Zacks Equity Research
HUM's first-quarter results reflect higher primary care revenues and a well-performing Medicare stand-alone PDP business, partly offset by elevated operating costs.
Tenet Beats Q1 Earnings on Strong Ambulatory Unit, Ups '25 EPS View
by Zacks Equity Research
THC's first-quarter results benefit on the back of higher net revenue per case and the expansion of service lines within the Ambulatory Care unit. It currently expects 2025 adjusted EPS within $11.99-$13.12.
3 Reasons Why Growth Investors Shouldn't Overlook HCA (HCA)
by Zacks Equity Research
HCA (HCA) could produce exceptional returns because of its solid growth attributes.
Why HCA Healthcare (HCA) is a Top Growth Stock for the Long-Term
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why HCA Healthcare (HCA) is a Top Value Stock for the Long-Term
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks Industry Outlook Highlights HCA Healthcare, Tenet Healthcare, Universal Health Services and Community Health Systems
by Zacks Equity Research
HCA Healthcare, Tenet Healthcare, Universal Health Services and Community Health Systems have been highlighted in this Industry Outlook article.
Encompass Health Beats Q1 Earnings Estimates, Ups '25 EPS View
by Zacks Equity Research
EHC's Q1 results benefit on the back of discharge growth and expansion endeavors, partly offset by high operating costs. It currently expects 2025 adjusted EPS from continuing operations within $4.85-$5.10.
Doctor's Orders: 4 Hospital Stocks to Benefit From Industry Trends
by Kaibalya Pravo Dey
The Zacks Medical-Hospital industry is likely to gain from growing demand, improving operating stability and finances. Companies like HCA, THC, UHS and CYH are poised to benefit from these trends.